Literature DB >> 21999112

European neuroborreliosis: neuropsychological findings 30 months post-treatment.

R Eikeland1, U Ljøstad, A Mygland, K Herlofson, G C Løhaugen.   

Abstract

BACKGROUND: The aim of this study was to compare neuropsychological (NP) functioning in patients with Lyme neuroborreliosis (LNB) 30months after treatment to matched controls.
METHODS: We tested 50 patients with LNB and 50 controls with the trail-making test (TMT), Stroop test, digit symbol test, and California Verbal Learning test (CVLT). A global NP sumscore was calculated to express the number of low scores on 23 NP subtasks.
RESULTS: Mean scores were lower amongst LNB-treated patients than amongst controls on tasks assessing attention/executive functions: (Stroop test 4: 77.6 vs. 67.0, P=0.015), response/processing speed (TMT 5: 23.4 vs. 19.2, P=0.004), visual memory (digit symbol recall: 6.6 vs. 7.2, P=0.038), and verbal memory (CVLT list B: 4.68 vs. 5.50, P=0.003). The proportion of patients and controls with NP sumscores within one SD from the mean in the control group (defined as normal) and between one and two SD (defined as deficit) were similar, but more LNB-treated patients than controls had a sumscore more than two SD from the mean (defined as impairment) (8 vs. 1, P=0.014).
CONCLUSIONS: As a group, LNB-treated patients scored lower on four NP subtasks assessing processing speed, visual and verbal memory, and executive/attention functions, as compared to matched controls. The distribution of NP dysfunctions indicates that most LNB-treated patients perform comparable to controls, whilst a small subgroup have a debilitating long-term course with cognitive problems.
© 2011 The Author(s). European Journal of Neurology © 2011 EFNS.

Entities:  

Mesh:

Year:  2011        PMID: 21999112     DOI: 10.1111/j.1468-1331.2011.03563.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

1.  Cognitive function in patients with neuroborreliosis: A prospective cohort study from the acute phase to 12 months post treatment.

Authors:  Silje Andreassen; Anne Marit Solheim; Unn Ljøstad; Åse Mygland; Åslaug Rudjord Lorentzen; Harald Reiso; Mona Kristiansen Beyer; Hanne Flinstad Harbo; Gro Christine Christensen Løhaugen; Randi Eikeland
Journal:  Brain Behav       Date:  2022-05-20       Impact factor: 3.405

2.  Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis.

Authors:  Rick Dersch; Antonia A Sarnes; Monika Maul; Tilman Hottenrott; Annette Baumgartner; Sebastian Rauer; Oliver Stich
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

3.  Impairments in Episodic-Autobiographical Memory and Emotional and Social Information Processing in CADASIL during Mid-Adulthood.

Authors:  Angelica Staniloiu; Friedrich G Woermann; Hans J Markowitsch
Journal:  Front Behav Neurosci       Date:  2014-06-25       Impact factor: 3.558

4.  Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization.

Authors:  Philipp Schwenkenbecher; Refik Pul; Ulrich Wurster; Josef Conzen; Kaweh Pars; Hans Hartmann; Kurt-Wolfram Sühs; Ludwig Sedlacek; Martin Stangel; Corinna Trebst; Thomas Skripuletz
Journal:  BMC Infect Dis       Date:  2017-01-21       Impact factor: 3.090

5.  Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study.

Authors:  Niels Obel; Ram B Dessau; Karen A Krogfelt; Jacob Bodilsen; Nanna S Andersen; Jens K Møller; Casper Roed; Lars H Omland; Claus B Christiansen; Svend Ellermann-Eriksen; Jette M Bangsborg; Klaus Hansen; Thomas L Benfield; Kenneth J Rothman; Henrik T Sørensen; Christian Ø Andersen; Anne-Mette Lebech
Journal:  BMJ       Date:  2018-05-30

6.  Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.

Authors:  Anneleen Berende; Hadewych J M Ter Hofstede; Fidel J Vos; Michiel L Vogelaar; Henriët van Middendorp; Andrea W M Evers; Roy P C Kessels; Bart Jan Kullberg
Journal:  Neurology       Date:  2019-02-22       Impact factor: 9.910

7.  Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial.

Authors:  Unn Ljøstad; Åse Mygland; Anne Marit Solheim
Journal:  BMJ Open       Date:  2019-06-14       Impact factor: 2.692

8.  Neurocognitive functions and brain atrophy after proven neuroborreliosis: a case-control study.

Authors:  Holger Schmidt; Marija Djukic; Klaus Jung; Manfred Holzgraefe; Peter Dechent; Nicole von Steinbüchel; Joachim Blocher; Helmut Eiffert; Carsten Schmidt-Samoa
Journal:  BMC Neurol       Date:  2015-08-19       Impact factor: 2.474

Review 9.  Imaging in Lyme neuroborreliosis.

Authors:  Elisabeth S Lindland; Anne Marit Solheim; Silje Andreassen; Else Quist-Paulsen; Randi Eikeland; Unn Ljøstad; Åse Mygland; Ahmed Elsais; Gro O Nygaard; Åslaug R Lorentzen; Hanne F Harbo; Mona K Beyer
Journal:  Insights Imaging       Date:  2018-09-04

10.  Detecting Borrelia Spirochetes: A Case Study With Validation Among Autopsy Specimens.

Authors:  Shiva Kumar Goud Gadila; Gorazd Rosoklija; Andrew J Dwork; Brian A Fallon; Monica E Embers
Journal:  Front Neurol       Date:  2021-05-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.